Massimo Caulo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Massimo Caulo has a total of 365 co-authors. Here are the top co-authors by number of shared publications:
- Andrea Delli Pizzi
Department of Innovative Technologies in Medicine and Dentistry, “G. d’Annunzio” University, 66100 Chieti, Italy
9 shared publications - Armando Tartaro
Department of Clinical Sciences and Bio-imaging “G. d’Annunzio” University and ITAB–Institute for Advanced Biomedical Technologies, “G. d’Annunzio” University Foundation, Chieti-Pescara, Italy
8 shared publications - Antonio Ferretti
Department of Clinical Sciences and Bio-imaging “G. d’Annunzio” University and ITAB–Institute for Advanced Biomedical Technologies, “G. d’Annunzio” University Foundation, Chieti-Pescara, Italy
6 shared publications - Carlo Sestieri
Department of Neuroscience, Imaging, and Clinical Sciences, University "G. d'Annunzio" of Chieti-Pescara, Italy; Institute for Advanced Biomedical Technologies (ITAB), University "G. d'Annunzio"of Chieti-Pescara, Italy
6 shared publications Gian Luca Romani
Institute Advanced Biomedical Technologies (ITAB), University “G. d’Annunzio” Chieti-Pescara, Chieti, Italy
6 shared publicationsC. Briganti
Department of Neuroscience and Imaging, G. d'Annunzio University, Chieti, Italy
5 shared publications
Latest Publications
- Open Access
- 22 June 2026
- Published by Springer Nature in Neurological Sciences
- Vol. 47 (7) , 584
ALIGNED Network for rare cerebrovascular diseases: methodology and preliminary results
Introduction: Cerebrovascular diseases are a major cause of morbidity/mortality worldwide, yet more than 30% of strokes remain of undetermined origin. Rare cerebrovascular diseases (rCVDs) contribute to this burden but are often underdiagnosed due to limited awareness, clinical heterogeneity, and fragmented diagnostic access. The ALIGNED project was established to address these gaps through a nationwide multidisciplinary network. Methods: ALIGNED was aimed to improve clinical/molecular characterization of rCVDs through standardized data collection, assess level of care of rCVDs by an online/on-site survey and reduce the geographical gap across Italy, by a virtual model of rCVDs care. In the first phase we conducted a survey to evaluate the availability of diagnostic/therapeutic pathways. Preliminary molecular profiling (i.e., transcriptomic/proteomic analyses) has been carried out on middle-cerebral artery and plasma samples from Moyamoya angiopathy (MMA) patients. Results: Fourty-nine centers adhered to the project. Initially, we collected a cohort of 308 subjects with rCVDs: CADASIL (162), COL4A1/A2-related disease (9), Sneddon syndrome (25), Fabry disease (32), and MMA (80). Web-based survey and site visits provided a representative overview of national capabilities in rCVD diagnosis and care. Transcriptomic analysis showed a peculiar expression profile of angiogenesis growth factors/inhibitors in MMA cerebral vessels. Plasma proteomic profiles of MMA patients highlighted circulating proteins expressed in dysfunctional angiogenesis. Discussion: Preliminary data suggested a substantial variability in the quality of rCVDs management and in the availability of diagnostic tools across Italy. Thus, mapping Italian expertise and facilities emerged as a crucial target for pinpointing gaps, improving resource allocation, standardizing rCVD care to guarantee equitable access for patients.
- 22 June 2026
- Published by Springer Nature in Neurological Sciences
- Vol. 47 (7) , 584
Open AccessALIGNED Network for rare cerebrovascular diseases: methodology and preliminary results
Introduction: Cerebrovascular diseases are a major cause of morbidity/mortality worldwide, yet more than 30% of strokes remain of undetermined origin. Rare cerebrovascular diseases (rCVDs) contribute to this burden but are often underdiagnosed due to limited awareness, clinical heterogeneity, and fragmented diagnostic access. The ALIGNED project was established to address these gaps through a nationwide multidisciplinary network. Methods: ALIGNED was aimed to improve clinical/molecular characterization of rCVDs through standardized data collection, assess level of care of rCVDs by an online/on-site survey and reduce the geographical gap across Italy, by a virtual model of rCVDs care. In the first phase we conducted a survey to evaluate the availability of diagnostic/therapeutic pathways. Preliminary molecular profiling (i.e., transcriptomic/proteomic analyses) has been carried out on middle-cerebral artery and plasma samples from Moyamoya angiopathy (MMA) patients. Results: Fourty-nine centers adhered to the project. Initially, we collected a cohort of 308 subjects with rCVDs: CADASIL (162), COL4A1/A2-related disease (9), Sneddon syndrome (25), Fabry disease (32), and MMA (80). Web-based survey and site visits provided a representative overview of national capabilities in rCVD diagnosis and care. Transcriptomic analysis showed a peculiar expression profile of angiogenesis growth factors/inhibitors in MMA cerebral vessels. Plasma proteomic profiles of MMA patients highlighted circulating proteins expressed in dysfunctional angiogenesis. Discussion: Preliminary data suggested a substantial variability in the quality of rCVDs management and in the availability of diagnostic tools across Italy. Thus, mapping Italian expertise and facilities emerged as a crucial target for pinpointing gaps, improving resource allocation, standardizing rCVD care to guarantee equitable access for patients.
- Open Access
- 25 May 2026
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 16 (6) , 281
Recurrence Patterns and Overtreatment in Pure DCIS: A Retrospective Clinical and Radiological Follow-Up Study
Background/Objectives: The clinical management of ductal carcinoma in situ (DCIS) remains controversial due to its heterogeneous biological behavior and uncertain risk of progression. Standard treatment often includes surgery and radiotherapy, although the actual recurrence risk varies considerably among patients. This study aimed to evaluate recurrence patterns and associated clinicopathological factors in a large single-center cohort of patients with pure DCIS. Methods: We retrospectively analyzed 403 patients with histologically confirmed pure DCIS treated with breast-conserving surgery or mastectomy between 2016 and 2023. Clinical, imaging, pathological, and treatment-related variables were assessed. Descriptive and exploratory comparative analyses were performed between patients with and without ipsilateral recurrence. Results: A total of 417 lesions were analyzed, with 21 ipsilateral recurrences (5%) observed during follow-up. Among recurrent cases, 57% were non-invasive recurrent DCIS and 38% were invasive carcinomas. Most recurrences occurred in patients treated with breast-conserving surgery, and 52% of recurrent patients had not received adjuvant radiotherapy. All recurrent cases were estrogen receptor–positive at initial diagnosis, whereas none had received endocrine therapy. No clear association between recurrence patterns and tumor grade or tumor size emerged in this exploratory analysis. No distant metastases or disease-related deaths were observed during follow-up. Conclusions: Recurrence after treatment for pure DCIS was relatively uncommon and frequently non-invasive. Traditional clinicopathological variables alone appeared insufficient to consistently identify recurrence patterns in this cohort. These findings support the need for more individualized risk stratification approaches integrating clinical, imaging, and molecular factors in order to reduce potential overtreatment in selected patients with DCIS.
- 25 May 2026
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 16 (6) , 281
Open AccessRecurrence Patterns and Overtreatment in Pure DCIS: A Retrospective Clinical and Radiological Follow-Up Study
Background/Objectives: The clinical management of ductal carcinoma in situ (DCIS) remains controversial due to its heterogeneous biological behavior and uncertain risk of progression. Standard treatment often includes surgery and radiotherapy, although the actual recurrence risk varies considerably among patients. This study aimed to evaluate recurrence patterns and associated clinicopathological factors in a large single-center cohort of patients with pure DCIS. Methods: We retrospectively analyzed 403 patients with histologically confirmed pure DCIS treated with breast-conserving surgery or mastectomy between 2016 and 2023. Clinical, imaging, pathological, and treatment-related variables were assessed. Descriptive and exploratory comparative analyses were performed between patients with and without ipsilateral recurrence. Results: A total of 417 lesions were analyzed, with 21 ipsilateral recurrences (5%) observed during follow-up. Among recurrent cases, 57% were non-invasive recurrent DCIS and 38% were invasive carcinomas. Most recurrences occurred in patients treated with breast-conserving surgery, and 52% of recurrent patients had not received adjuvant radiotherapy. All recurrent cases were estrogen receptor–positive at initial diagnosis, whereas none had received endocrine therapy. No clear association between recurrence patterns and tumor grade or tumor size emerged in this exploratory analysis. No distant metastases or disease-related deaths were observed during follow-up. Conclusions: Recurrence after treatment for pure DCIS was relatively uncommon and frequently non-invasive. Traditional clinicopathological variables alone appeared insufficient to consistently identify recurrence patterns in this cohort. These findings support the need for more individualized risk stratification approaches integrating clinical, imaging, and molecular factors in order to reduce potential overtreatment in selected patients with DCIS.
- 1 May 2026
- Published by Wolters Kluwer Health in Stroke
- Vol. 57 (5) , 1382-1387
Middle Meningeal Artery Embolization Is Associated With Lower Risk of Incident Dementia Among Patients With Subdural Hematoma
BACKGROUND: Nonacute subdural hematoma (NASDH) is associated with cognitive dysfunction and decline. Middle meningeal artery embolization (MMAE) has shown efficacy in reducing NASDH recurrence and promoting hematoma resorption, but its potential impact on long-term cognitive outcomes is unexplored. This study aims to determine whether standalone MMAE is associated with reduced dementia risk compared with conservative management (CM) in dementia-free patients with nonsurgical NASDH. METHODS: This was a multicenter retrospective cohort study using the TriNetX US collaborative research network database. Adult patients with newly diagnosed NASDH who did not undergo surgical drainage were included. Patients with known dementia at the time of NASDH diagnosis were excluded. Patients who underwent standalone MMAE were compared with those who underwent CM only. The primary outcome was new-onset dementia during a 5-year study follow-up period. Secondary outcomes included all-cause mortality. One-to-one propensity score matching was performed to account for confounding and indication bias. Outcomes were compared using time-to-event analyses with Kaplan-Meier curves and Cox proportional hazards models. RESULTS: Of 175 868 patients with nonsurgical NASDH, 1991 underwent MMAE. After propensity score matching, 1972 patients remained in each group with similar baseline characteristics (all absolute standardized differences P P =0.001). CONCLUSIONS: Among nonsurgical, dementia-free patients with NASDH, standalone MMAE was associated with significantly reduced incident dementia risk compared with CM. These findings suggest MMAE may provide neurocognitive benefits beyond preventing hematoma progression, potentially through promoting hematoma resorption and preserving cortical integrity. Prospective studies are needed to confirm these hypothesis-generating observations and establish causality.
- 1 May 2026
- Published by Wolters Kluwer Health in Stroke
- Vol. 57 (5) , 1382-1387
Middle Meningeal Artery Embolization Is Associated With Lower Risk of Incident Dementia Among Patients With Subdural Hematoma
BACKGROUND: Nonacute subdural hematoma (NASDH) is associated with cognitive dysfunction and decline. Middle meningeal artery embolization (MMAE) has shown efficacy in reducing NASDH recurrence and promoting hematoma resorption, but its potential impact on long-term cognitive outcomes is unexplored. This study aims to determine whether standalone MMAE is associated with reduced dementia risk compared with conservative management (CM) in dementia-free patients with nonsurgical NASDH. METHODS: This was a multicenter retrospective cohort study using the TriNetX US collaborative research network database. Adult patients with newly diagnosed NASDH who did not undergo surgical drainage were included. Patients with known dementia at the time of NASDH diagnosis were excluded. Patients who underwent standalone MMAE were compared with those who underwent CM only. The primary outcome was new-onset dementia during a 5-year study follow-up period. Secondary outcomes included all-cause mortality. One-to-one propensity score matching was performed to account for confounding and indication bias. Outcomes were compared using time-to-event analyses with Kaplan-Meier curves and Cox proportional hazards models. RESULTS: Of 175 868 patients with nonsurgical NASDH, 1991 underwent MMAE. After propensity score matching, 1972 patients remained in each group with similar baseline characteristics (all absolute standardized differences P P =0.001). CONCLUSIONS: Among nonsurgical, dementia-free patients with NASDH, standalone MMAE was associated with significantly reduced incident dementia risk compared with CM. These findings suggest MMAE may provide neurocognitive benefits beyond preventing hematoma progression, potentially through promoting hematoma resorption and preserving cortical integrity. Prospective studies are needed to confirm these hypothesis-generating observations and establish causality.
- Open Access
- 5 March 2026
- Published by Springer Nature in La radiologia medica
- Vol. 131 (6) , 970-986
Radiologic exposomics: imaging the environmental imprint on cancer for precision oncology
Environmental exposures—such as airborne pollutants, metals, and urban stressors—contribute to cancer development and progression, yet their downstream biological effects remain difficult to characterize in vivo. Quantitative medical imaging may help fill this gap. Radiomics, in particular, offers access to tissue-level patterns shaped by chronic injury and microenvironmental remodeling. In this review, we discuss the rationale for linking geospatial exposure assessment with CT- and MRI-derived imaging biomarkers and outline how radiologic features may reflect processes associated with long-term environmental stress, including oxidative damage, inflammation, and metabolic or immune dysregulation. We also summarize epidemiologic evidence across major cancer types to contextualize where imaging–exposure integration is most plausible. A methodological workflow is presented, covering exposure assignment, imaging standardization, feature extraction, and strategies for harmonizing and modeling high-dimensional exposomic and radiomic data. Considerations related to confounding, data governance, and equity are also addressed, as these factors are integral to responsible implementation. Viewed in this light, imaging can be interpreted as an intermediate phenotype of the exposome—capturing aspects of tumor and peritumoral biology influenced by external stressors. This perspective may expand the role of radiology in precision oncology and generate new hypotheses about how environmental conditions shape cancer biology.
- 5 March 2026
- Published by Springer Nature in La radiologia medica
- Vol. 131 (6) , 970-986
Open AccessRadiologic exposomics: imaging the environmental imprint on cancer for precision oncology
Environmental exposures—such as airborne pollutants, metals, and urban stressors—contribute to cancer development and progression, yet their downstream biological effects remain difficult to characterize in vivo. Quantitative medical imaging may help fill this gap. Radiomics, in particular, offers access to tissue-level patterns shaped by chronic injury and microenvironmental remodeling. In this review, we discuss the rationale for linking geospatial exposure assessment with CT- and MRI-derived imaging biomarkers and outline how radiologic features may reflect processes associated with long-term environmental stress, including oxidative damage, inflammation, and metabolic or immune dysregulation. We also summarize epidemiologic evidence across major cancer types to contextualize where imaging–exposure integration is most plausible. A methodological workflow is presented, covering exposure assignment, imaging standardization, feature extraction, and strategies for harmonizing and modeling high-dimensional exposomic and radiomic data. Considerations related to confounding, data governance, and equity are also addressed, as these factors are integral to responsible implementation. Viewed in this light, imaging can be interpreted as an intermediate phenotype of the exposome—capturing aspects of tumor and peritumoral biology influenced by external stressors. This perspective may expand the role of radiology in precision oncology and generate new hypotheses about how environmental conditions shape cancer biology.
- 23 February 2026
- Published by American Society of Neuroradiology (ASNR) in American Journal of Neuroradiology
- Vol. 47 (9) , ajnr.A9259-2423
GROWING FOLDS: FETAL MR IMAGING ANATOMY OF THE HIPPOCAMPAL HEAD DIGITATIONS
The adult hippocampal head (HH) is characterized by sulci and digitations visible both histologically and on MRI. The aim of the study was to describe the emergence and progression of HH digitations in the fetal brain across different gestational ages (GA) using MRI. A retrospective assessment was performed on 383 fetal brain MRIs (19-39 weeks GA) acquired on 1.5T (n=351) and 3T (n=32) scanners. Imaging included ssFSE T2, T1-weighted sequences, and axial DWI. The fetal HH was identified on coronal T2 images and HH morphological variants were classified using an established adult classification system as: Class 0 (no sulci, one digitation), Class 1 (one sulcus, two digitations), and Class 2 (two sulci, three digitations). MRIs with brain anomalies identified prenatally or postnatally, abnormal sulcation, or severe artifacts were excluded. Variant frequencies in both hemispheres were grouped by GA. Correspondence Analysis and Cumulative Link Mixed Models were used to assess the association between GA and class distribution. 271 fetuses were included, grouped into eight GA categories. Overall frequencies were 33.6% for Class 0, 48.9% for Class 1, and 17.5% for Class 2. With increasing GA, class 0 frequency decreased, while Classes 1 and 2 increased. Between 23- and 25-weeks GA, detection of more digitated HH variants rose sharply from 1% to 64%. Follow-up in 30 fetuses showed an increase in HH digitations, with no observed reductions. Regression analysis revealed greater digitation complexity in the right hemisphere. Digitations in the fetal HH begin to appear around 24 weeks GA, reaching frequencies similar to those observed in adults by the later stages of gestation. The right hemisphere shows higher complexity, possibly reflecting faster growth. These findings contribute to the understanding of hippocampal development and may serve as a biomarker of fetal brain maturation.
- 23 February 2026
- Published by American Society of Neuroradiology (ASNR) in American Journal of Neuroradiology
- Vol. 47 (9) , ajnr.A9259-2423
GROWING FOLDS: FETAL MR IMAGING ANATOMY OF THE HIPPOCAMPAL HEAD DIGITATIONS
The adult hippocampal head (HH) is characterized by sulci and digitations visible both histologically and on MRI. The aim of the study was to describe the emergence and progression of HH digitations in the fetal brain across different gestational ages (GA) using MRI. A retrospective assessment was performed on 383 fetal brain MRIs (19-39 weeks GA) acquired on 1.5T (n=351) and 3T (n=32) scanners. Imaging included ssFSE T2, T1-weighted sequences, and axial DWI. The fetal HH was identified on coronal T2 images and HH morphological variants were classified using an established adult classification system as: Class 0 (no sulci, one digitation), Class 1 (one sulcus, two digitations), and Class 2 (two sulci, three digitations). MRIs with brain anomalies identified prenatally or postnatally, abnormal sulcation, or severe artifacts were excluded. Variant frequencies in both hemispheres were grouped by GA. Correspondence Analysis and Cumulative Link Mixed Models were used to assess the association between GA and class distribution. 271 fetuses were included, grouped into eight GA categories. Overall frequencies were 33.6% for Class 0, 48.9% for Class 1, and 17.5% for Class 2. With increasing GA, class 0 frequency decreased, while Classes 1 and 2 increased. Between 23- and 25-weeks GA, detection of more digitated HH variants rose sharply from 1% to 64%. Follow-up in 30 fetuses showed an increase in HH digitations, with no observed reductions. Regression analysis revealed greater digitation complexity in the right hemisphere. Digitations in the fetal HH begin to appear around 24 weeks GA, reaching frequencies similar to those observed in adults by the later stages of gestation. The right hemisphere shows higher complexity, possibly reflecting faster growth. These findings contribute to the understanding of hippocampal development and may serve as a biomarker of fetal brain maturation.
- Open Access
- 31 October 2025
- Published by Elsevier in Current Problems in Diagnostic Radiology
- Vol. 55 (4) , 563-568
“Diagnostic accuracy and longitudinal outcomes of PI-RADS 3 lesions: A multi-reader comparison between biparametric and multiparametric MRI”
- 31 October 2025
- Published by Elsevier in Current Problems in Diagnostic Radiology
- Vol. 55 (4) , 563-568
Open Access“Diagnostic accuracy and longitudinal outcomes of PI-RADS 3 lesions: A multi-reader comparison between biparametric and multiparametric MRI”
- 7 June 2025
- Published by Springer Nature in La radiologia medica
- p. 1-11
Aortic valve and coronary artery calcium scoring: impact of half- versus standard-dose protocols
Aims CT acquisition parameters and reconstruction techniques may affect the accuracy of calcium scoring measurements with a potential impact on clinical decision making. We evaluated the agreement of half- versus standard-dose protocols for assessment of aortic valve (AVCS HD and AVCS SD protocols) and coronary artery calcium scoring (CACS HD and CACS SD protocols) with and without the application of iterative reconstruction. Methods We enrolled 144 consecutive patients (mean age 83 ± 9 years) with known aortic stenosis undergoing 128-row prospective sequential CT with standard (120 kVp/20 mAs) and half-dose (120 kVp/10 mAs) protocols for both AVCS and CACS evaluation. The half-dose dataset was processed with and without iterative reconstruction. Agreement and precision of different protocols were evaluated using linear regression and Bland–Altman analysis. Additionally, we assessed the reclassification of cardiovascular risk based on the Mayo Clinic system and the likelihood of severe aortic stenosis using sex-specific categories. Results Compared with the standard dose, the half-dose protocol with or without iterative reconstruction demonstrated optimum agreement for the evaluation of AVCS (r = 0.99; R2 = 0.97) and CACS (r = 0.96; R2 = 0.93). The half-dose iterative reconstruction protocol yielded a very low rate of reclassification aortic stenosis severity (1.4%) and cardiovascular risk (6.2%). The half-dose protocol resulted in 47.5% radiation dose reduction compared to standard dose (dose-length product: 8.5 ± 1.1 vs. 17.9 ± 2.7; p < 0.001). Conclusions Our findings suggest that the half-dose protocol with iterative reconstruction provides reliable and accurate results for both AVCS and CACS assessment. This evidence underscores the potential to optimize radiation dose while preserving the precision of diagnostic outcomes, thereby minimally impacting clinical management.
- 7 June 2025
- Published by Springer Nature in La radiologia medica
- p. 1-11
Aortic valve and coronary artery calcium scoring: impact of half- versus standard-dose protocols
Aims CT acquisition parameters and reconstruction techniques may affect the accuracy of calcium scoring measurements with a potential impact on clinical decision making. We evaluated the agreement of half- versus standard-dose protocols for assessment of aortic valve (AVCS HD and AVCS SD protocols) and coronary artery calcium scoring (CACS HD and CACS SD protocols) with and without the application of iterative reconstruction. Methods We enrolled 144 consecutive patients (mean age 83 ± 9 years) with known aortic stenosis undergoing 128-row prospective sequential CT with standard (120 kVp/20 mAs) and half-dose (120 kVp/10 mAs) protocols for both AVCS and CACS evaluation. The half-dose dataset was processed with and without iterative reconstruction. Agreement and precision of different protocols were evaluated using linear regression and Bland–Altman analysis. Additionally, we assessed the reclassification of cardiovascular risk based on the Mayo Clinic system and the likelihood of severe aortic stenosis using sex-specific categories. Results Compared with the standard dose, the half-dose protocol with or without iterative reconstruction demonstrated optimum agreement for the evaluation of AVCS (r = 0.99; R2 = 0.97) and CACS (r = 0.96; R2 = 0.93). The half-dose iterative reconstruction protocol yielded a very low rate of reclassification aortic stenosis severity (1.4%) and cardiovascular risk (6.2%). The half-dose protocol resulted in 47.5% radiation dose reduction compared to standard dose (dose-length product: 8.5 ± 1.1 vs. 17.9 ± 2.7; p < 0.001). Conclusions Our findings suggest that the half-dose protocol with iterative reconstruction provides reliable and accurate results for both AVCS and CACS assessment. This evidence underscores the potential to optimize radiation dose while preserving the precision of diagnostic outcomes, thereby minimally impacting clinical management.
- Open Access
- 12 March 2025
- Published by MDPI AG in Diagnostics
- Vol. 15 (6) , 706
Atherosclerotic Abdominal Aortic Aneurysms on Computed Tomography Angiography: A Narrative Review on Spectrum of Findings, Structured Reporting, Treatment, Secondary Complications and Differential Diagnosis
Atherosclerotic abdominal aortic aneurysms (AAAs) are a common vascular pathology with significant morbidity and mortality risks. Timely diagnosis, accurate characterization, and standardized reporting are critical for effective management and monitoring of atherosclerotic AAAs. Imaging modalities, particularly computed tomography angiography (CTA), play a pivotal role in the detection, treatment planning, and identification of both primary and secondary complications, as well as distinguishing AAAs from other etiologies. This narrative review provides a comprehensive exploration of the spectrum of imaging findings in atherosclerotic AAAs on CTA, underscoring the importance of structured reporting. Additionally, it examines therapeutic approaches and complications, and it differentiates AAAs from inflammatory, mycotic, and traumatic variants, serving as a primer for radiologists in AAA evaluation.
- 12 March 2025
- Published by MDPI AG in Diagnostics
- Vol. 15 (6) , 706
Open AccessAtherosclerotic Abdominal Aortic Aneurysms on Computed Tomography Angiography: A Narrative Review on Spectrum of Findings, Structured Reporting, Treatment, Secondary Complications and Differential Diagnosis
Atherosclerotic abdominal aortic aneurysms (AAAs) are a common vascular pathology with significant morbidity and mortality risks. Timely diagnosis, accurate characterization, and standardized reporting are critical for effective management and monitoring of atherosclerotic AAAs. Imaging modalities, particularly computed tomography angiography (CTA), play a pivotal role in the detection, treatment planning, and identification of both primary and secondary complications, as well as distinguishing AAAs from other etiologies. This narrative review provides a comprehensive exploration of the spectrum of imaging findings in atherosclerotic AAAs on CTA, underscoring the importance of structured reporting. Additionally, it examines therapeutic approaches and complications, and it differentiates AAAs from inflammatory, mycotic, and traumatic variants, serving as a primer for radiologists in AAA evaluation.
- Open Access
- 14 November 2024
- Published by MDPI AG in Preprints.org
Usefulness of Polydeoxyribonucleotide in Lateral Epicondylitis Injection Therapy: A New Strategy for a Rapid Pain Reduction and Functional Recovery for Tennis Players
Background: This study assesses the efficacy of polydeoxyribonucleotide (PDRN) injection therapy in treating lateral epicondylitis (LE), commonly known as tennis elbow. Methods: The study included twelve patients who had persisting pain for more than six weeks and had failed conservative therapy. The patients (M: 7; F: 5; age: 46 ± 12 years old) received three PDRN injections in different sessions over eight weeks. Pain was assessed using the Visual Analogue Scale (VAS) and the Clinical Global Impression-Improvement (CGI-I) scale in five different evaluation times (T0= baseline, up to T4= 6 months after treatment beginning. Results: The VAS scores were reduced by an average of 40% at T2 compared to baseline, indicating a significant clinical improvement. The CGI-I scale showed a reduction of at least 3 points between T2 and the baseline visit, which is considered clinically significant. Ultrasound evaluation was also performed to assess tendon trophism, and PDRN was found to have a trophic/reparative effect on the tendon. Conclusions: the preliminary data suggest that PDRN injection could be an efficacy treatment for lateral epicondylitis in terms of pain reduction and tendon trophism. Further investigations are warranted to validate these findings and explore the broader applicability of PDRN in tendinopathies.
- 14 November 2024
- Published by MDPI AG in Preprints.org
Open AccessUsefulness of Polydeoxyribonucleotide in Lateral Epicondylitis Injection Therapy: A New Strategy for a Rapid Pain Reduction and Functional Recovery for Tennis Players
Background: This study assesses the efficacy of polydeoxyribonucleotide (PDRN) injection therapy in treating lateral epicondylitis (LE), commonly known as tennis elbow. Methods: The study included twelve patients who had persisting pain for more than six weeks and had failed conservative therapy. The patients (M: 7; F: 5; age: 46 ± 12 years old) received three PDRN injections in different sessions over eight weeks. Pain was assessed using the Visual Analogue Scale (VAS) and the Clinical Global Impression-Improvement (CGI-I) scale in five different evaluation times (T0= baseline, up to T4= 6 months after treatment beginning. Results: The VAS scores were reduced by an average of 40% at T2 compared to baseline, indicating a significant clinical improvement. The CGI-I scale showed a reduction of at least 3 points between T2 and the baseline visit, which is considered clinically significant. Ultrasound evaluation was also performed to assess tendon trophism, and PDRN was found to have a trophic/reparative effect on the tendon. Conclusions: the preliminary data suggest that PDRN injection could be an efficacy treatment for lateral epicondylitis in terms of pain reduction and tendon trophism. Further investigations are warranted to validate these findings and explore the broader applicability of PDRN in tendinopathies.
- Open Access
Machine Learning Analysis in Diffusion Kurtosis Imaging for Discriminating Pediatric Posterior Fossa Tumors: A Repeatability and Accuracy Pilot Study
Background and purpose: Differentiating pediatric posterior fossa (PF) tumors such as medulloblastoma (MB), ependymoma (EP), and pilocytic astrocytoma (PA) remains relevant, because of important treatment and prognostic implications. Diffusion kurtosis imaging (DKI) has not yet been investigated for discrimination of pediatric PF tumors. Estimating diffusion values from whole-tumor-based (VOI) segmentations may improve diffusion measurement repeatability compared to conventional region-of-interest (ROI) approaches. Our purpose was to compare repeatability between ROI and VOI DKI-derived diffusion measurements and assess DKI accuracy in discriminating among pediatric PF tumors. Materials and methods: We retrospectively analyzed 34 children (M, F, mean age 7.48 years) with PF tumors who underwent preoperative examination on a 3 Tesla magnet, including DKI. For each patient, two neuroradiologists independently segmented the whole solid tumor, the ROI of the area of maximum tumor diameter, and a small 5 mm ROI. The automated analysis pipeline included inter-observer variability, statistical, and machine learning (ML) analyses. We evaluated inter-observer variability with coefficient of variation (COV) and Bland–Altman plots. We estimated DKI metrics accuracy in discriminating among tumor histology with MANOVA analysis. In order to account for class imbalances, we applied SMOTE to balance the dataset. Finally, we performed a Random Forest (RF) machine learning classification analysis based on all DKI metrics from the SMOTE dataset by partitioning 70/30 the training and testing cohort. Results: Tumor histology included medulloblastoma (15), pilocytic astrocytoma (14), and ependymoma (5). VOI-based measurements presented lower variability than ROI-based measurements across all DKI metrics and were used for the analysis. DKI-derived metrics could accurately discriminate between tumor subtypes (Pillai’s trace: p < 0.001). SMOTE generated 11 synthetic observations (10 EP and 1 PA), resulting in a balanced dataset with 45 instances (34 original and 11 synthetic). ML analysis yielded an accuracy of 0.928, which correctly predicted all but one lesion in the testing set. Conclusions: VOI-based measurements presented improved repeatability compared to ROI-based measurements across all diffusion metrics. An ML classification algorithm resulted accurate in discriminating PF tumors on a SMOTE-generated dataset. ML techniques based on DKI-derived metrics are useful for the discrimination of pediatric PF tumors.
Open AccessMachine Learning Analysis in Diffusion Kurtosis Imaging for Discriminating Pediatric Posterior Fossa Tumors: A Repeatability and Accuracy Pilot Study
Background and purpose: Differentiating pediatric posterior fossa (PF) tumors such as medulloblastoma (MB), ependymoma (EP), and pilocytic astrocytoma (PA) remains relevant, because of important treatment and prognostic implications. Diffusion kurtosis imaging (DKI) has not yet been investigated for discrimination of pediatric PF tumors. Estimating diffusion values from whole-tumor-based (VOI) segmentations may improve diffusion measurement repeatability compared to conventional region-of-interest (ROI) approaches. Our purpose was to compare repeatability between ROI and VOI DKI-derived diffusion measurements and assess DKI accuracy in discriminating among pediatric PF tumors. Materials and methods: We retrospectively analyzed 34 children (M, F, mean age 7.48 years) with PF tumors who underwent preoperative examination on a 3 Tesla magnet, including DKI. For each patient, two neuroradiologists independently segmented the whole solid tumor, the ROI of the area of maximum tumor diameter, and a small 5 mm ROI. The automated analysis pipeline included inter-observer variability, statistical, and machine learning (ML) analyses. We evaluated inter-observer variability with coefficient of variation (COV) and Bland–Altman plots. We estimated DKI metrics accuracy in discriminating among tumor histology with MANOVA analysis. In order to account for class imbalances, we applied SMOTE to balance the dataset. Finally, we performed a Random Forest (RF) machine learning classification analysis based on all DKI metrics from the SMOTE dataset by partitioning 70/30 the training and testing cohort. Results: Tumor histology included medulloblastoma (15), pilocytic astrocytoma (14), and ependymoma (5). VOI-based measurements presented lower variability than ROI-based measurements across all DKI metrics and were used for the analysis. DKI-derived metrics could accurately discriminate between tumor subtypes (Pillai’s trace: p < 0.001). SMOTE generated 11 synthetic observations (10 EP and 1 PA), resulting in a balanced dataset with 45 instances (34 original and 11 synthetic). ML analysis yielded an accuracy of 0.928, which correctly predicted all but one lesion in the testing set. Conclusions: VOI-based measurements presented improved repeatability compared to ROI-based measurements across all diffusion metrics. An ML classification algorithm resulted accurate in discriminating PF tumors on a SMOTE-generated dataset. ML techniques based on DKI-derived metrics are useful for the discrimination of pediatric PF tumors.